20182019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2019

  • 3 Article
  • 1 Comment/Letter to the editor

RX-3117 (fluorocyclopentenyl cytosine): a novel specific antimetabolite for selective cancer treatment

Balboni, B., el Hassouni, B., Honeywell, R. J., Sarkisjan, D., Giovannetti, E., Poore, J., Heaton, C., Peterson, C., Benaim, E., Lee, Y. B., Kim, D. J. & Peters, G. J., 2019, In : Expert Opinion on Investigational Drugs. 28, 4, p. 311-322

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma

Sciarrillo, R., Wojtuszkiewicz, A., El Hassouni, B., Funel, N., Gandellini, P., Lagerweij, T., Buonamici, S., Blijlevens, M., Zeeuw van der Laan, E. A., Zaffaroni, N., Deraco, M., Kusamura, S., Würdinger, T., Peters, G. J., Molthoff, C. F. M., Jansen, G., Kaspers, G. J. L., Cloos, J. & Giovannetti, E., Jan 2019, In : EBioMedicine. 39, p. 215-225

Research output: Contribution to journalArticleAcademicpeer-review

Multidrug-resistant transporter expression does not always result in drug resistance

le Large, T. Y. S., el Hassouni, B., Kazemier, G., Piersma, S. R., van Laarhoven, H. W. M., Bijlsma, M. F., Jimenez, C. R. & Giovannetti, E., 2018, In : Cancer Science. 109, 10, p. 3360-3362 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Open Access

Targeting the ribosome biogenesis key molecule fibrillarin to avoid chemoresistance

El Hassouni, B., Sarkisjan, D., Vos, J. C., Giovannetti, E. & Peters, G. J., 3 Dec 2018, In : Current Medicinal Chemistry.

Research output: Contribution to journalArticleAcademicpeer-review